Biotricity Stock Probability of Future Stock Price Finishing Over 0.714

BTCY Stock  USD 1.46  0.11  8.15%   
Biotricity's implied volatility is one of the determining factors in the pricing options written on Biotricity. Implied volatility approximates the future value of Biotricity based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Biotricity over a specific time period. For example, 2024-05-17 PUT at $2.5 is a PUT option contract on Biotricity's common stock with a strick price of 2.5 expiring on 2024-05-17. The contract was not traded in recent days and, as of today, has 25 days remaining before the expiration. The option is currently trading at a bid price of $0.9, and an ask price of $2.2. The implied volatility as of the 23rd of April is 452.95. View All Biotricity options

Closest to current price Biotricity long PUT Option Payoff at Expiration

Biotricity's future price is the expected price of Biotricity instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Biotricity performance during a given time horizon utilizing its historical volatility. Check out Biotricity Backtesting, Biotricity Valuation, Biotricity Correlation, Biotricity Hype Analysis, Biotricity Volatility, Biotricity History as well as Biotricity Performance.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
  
Price To Sales Ratio is likely to drop to 0.46 in 2024. Price Earnings Ratio is likely to drop to -1.95 in 2024. Please specify Biotricity's target price for which you would like Biotricity odds to be computed.

Biotricity Target Price Odds to finish over 0.714

The tendency of Biotricity Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 0.71  in 90 days
 1.46 90 days 0.71 
roughly 96.0
Based on a normal probability distribution, the odds of Biotricity to stay above $ 0.71  in 90 days from now is roughly 96.0 (This Biotricity probability density function shows the probability of Biotricity Stock to fall within a particular range of prices over 90 days) . Probability of Biotricity price to stay between $ 0.71  and its current price of $1.46 at the end of the 90-day period is about 89.3 .
Given the investment horizon of 90 days Biotricity has a beta of -0.7 suggesting as returns on the benchmark increase, returns on holding Biotricity are expected to decrease at a much lower rate. During a bear market, however, Biotricity is likely to outperform the market. Additionally Biotricity has an alpha of 0.8153, implying that it can generate a 0.82 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Biotricity Price Density   
       Price  

Predictive Modules for Biotricity

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biotricity. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biotricity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.071.3010.08
Details
Intrinsic
Valuation
LowRealHigh
0.102.0010.78
Details
1 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.39-0.36-0.39
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Biotricity. Your research has to be compared to or analyzed against Biotricity's peers to derive any actionable benefits. When done correctly, Biotricity's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Biotricity.

Biotricity Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Biotricity is not an exception. The market had few large corrections towards the Biotricity's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biotricity, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biotricity within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.82
β
Beta against NYSE Composite-0.7
σ
Overall volatility
0.23
Ir
Information ratio 0.08

Biotricity Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biotricity for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biotricity can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Biotricity is way too risky over 90 days horizon
Biotricity may become a speculative penny stock
Biotricity appears to be risky and price may revert if volatility continues
Biotricity has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 9.64 M. Net Loss for the year was (18.66 M) with profit before overhead, payroll, taxes, and interest of 4.57 M.
Biotricity currently holds about 2.89 M in cash with (13.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Biotricity has a poor financial position based on the latest SEC disclosures
Roughly 15.0% of the company shares are held by company insiders
Latest headline from investing.com: Biotricity pilots cardiac tech at major hospital network

Biotricity Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biotricity Stock often depends not only on the future outlook of the current and potential Biotricity's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biotricity's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding8.7 M
Cash And Short Term Investments570.5 K

Biotricity Technical Analysis

Biotricity's future price can be derived by breaking down and analyzing its technical indicators over time. Biotricity Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biotricity. In general, you should focus on analyzing Biotricity Stock price patterns and their correlations with different microeconomic environments and drivers.

Biotricity Predictive Forecast Models

Biotricity's time-series forecasting models is one of many Biotricity's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biotricity's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Biotricity

Checking the ongoing alerts about Biotricity for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biotricity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Biotricity is way too risky over 90 days horizon
Biotricity may become a speculative penny stock
Biotricity appears to be risky and price may revert if volatility continues
Biotricity has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 9.64 M. Net Loss for the year was (18.66 M) with profit before overhead, payroll, taxes, and interest of 4.57 M.
Biotricity currently holds about 2.89 M in cash with (13.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Biotricity has a poor financial position based on the latest SEC disclosures
Roughly 15.0% of the company shares are held by company insiders
Latest headline from investing.com: Biotricity pilots cardiac tech at major hospital network
When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:
Check out Biotricity Backtesting, Biotricity Valuation, Biotricity Correlation, Biotricity Hype Analysis, Biotricity Volatility, Biotricity History as well as Biotricity Performance.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stocks Directory
Find actively traded stocks across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.75)
Revenue Per Share
1.319
Quarterly Revenue Growth
0.209
Return On Assets
(0.95)
Return On Equity
(41.01)
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.